JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258891

Human GTF2F1 knockout HEK-293T cell lysate

Be the first to review this product! 리뷰 제출

|

(0 출판물)

GTF2F1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 3.
1 이미지
Sanger Sequencing - Human GTF2F1 knockout HEK-293T cell lysate (AB258891)
  • Sanger seq

Unknown

Sanger Sequencing - Human GTF2F1 knockout HEK-293T cell lysate (AB258891)

Homozygous : 2 bp deletion in exon 3

주요 정보

세포 유형

HEK-293T

Species or organism

Human

조직

Kidney

Knockout 검증

Sanger Sequencing

Mutation 정보

Knockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 3.

제품 세부 정보

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258891-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human GTF2F1 knockout HEK293T cell lysate", "number":"AB258891-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258891-CMP02", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
GTF2F1
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing
Zygosity
Homozygous
배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

GTF2F1 also known as General Transcription Factor IIF Subunit 1 plays an important role in transcription initiation. It weighs around 55 kDa and is expressed in various cell types across human tissues. GTF2F1 acts as a part of the transcription preinitiation complex that interacts with RNA polymerase II. This protein consists of distinct domains that mediate its role in facilitating the recruitment of RNA polymerase II to specific gene promoters.
Biological function summary

The General Transcription Factor IIF Subunit 1 (GTF2F1) functions as part of the transcription machinery specifically as a component of the transcription factor IIF (TFIIF) complex. It contributes to the stabilization and proper function of RNA polymerase II during transcription initiation and reinitiation. The TFIIF complex includes other subunits such as GTF2F2 that work together to manage transcription accuracy and processivity. This complex binds to DNA and RNA polymerase II impacting how transcription is executed across the genome.

Pathways

GTF2F1 participates in the RNA polymerase II transcription initiation pathway which is central to the synthesis of mRNA from DNA templates. This pathway involves several other general transcription factors like TFIID. GTF2F1 also influences the positive transcription elongation factor b (P-TEFb) pathway which helps regulate transcription elongation by phosphorylating the RNA polymerase II C-terminal domain. Through these pathways GTF2F1 indirectly associates with numerous gene expression regulatory mechanisms.

Abnormal function or expression of GTF2F1 connects to cancer and neurodegenerative diseases. In cancer dysregulation in transcription may lead to uncontrolled cell proliferation. Other proteins such as TFIID and TFIIB also interact within this context affecting the transcription regulatory landscape. In neurodegenerative diseases disrupted gene expression involving GTF2F1 and its associated complexes may contribute to disease progression linking transcription inaccuracies to cell dysfunction and death.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com